US Patent

US10660908 — Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid

Method of Use · Assigned to Leo Pharma AS · Expires 2031-06-10 · 5y remaining

Vulnerability score 68/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a topical spray composition that combines a vitamin D derivative with a corticosteroid for treating dermal diseases and conditions.

USPTO Abstract

The present invention relates to a topical spray composition comprising a biologically active vitamin D derivative or analogue and a corticosteroid, and its use in the treatment of dermal diseases and conditions.

Drugs covered by this patent

Diprolene (BETAMETHASONE DIPROPIONATE) · Merck & Co.

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-2627`	—	Diprolene

Patent Metadata

Patent number: US10660908
Jurisdiction: US
Classification: Method of Use
Expires: 2031-06-10
Drug substance claim: No
Drug product claim: Yes
Assignee: Leo Pharma AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.